PFS Investments’s ResMed RMD Stock Holding History

PFS Investments’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,325	Closed	-$205K	–	280
2019 Q4	$205K	Buy	+1,325	New	+$191K	0.01%	239

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PFS Investments's RMD Position: Q1 2020 in Review

PFS Investments sold out of ResMed (RMD) in Q1 2020, closing a stake of 1,325 shares — an estimated $205K sold.

PFS Investments first reported a position in RMD in Q4 2019 and held it in 1 quarter. The position peaked at $205K in Q4 2019. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

PFS Investments reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
PFS Investments sold 1,325 ResMed shares in Q1 2020, an estimated $205K.
PFS Investments first reported a position in ResMed in Q4 2019 and held it in 1 quarter.
PFS Investments's ResMed position peaked at $205K in Q4 2019.
584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on PFS Investments's 13F filing for Q1 2020, filed 13 May 2020.